loading...| Preferred Name |
Hetastarch |
|
| Synonyms |
|
|
| Definitions |
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C559 |
|
| CAS_Registry |
9005-27-0 |
|
| Chemical_Formula |
(C6H7O5)n.C2H5O.H |
|
| code |
C559 |
|
| Contributing_Source |
FDA |
|
| definition |
A synthetic, nonionic hydroxyethyl derivative of starch used as a plasma expander when prepared in an isotonic solution. Upon intravenous administration, hydroxyethyl starch colloid increases blood volume and thus improves circulation. This agent is almost exclusively excreted by the kidneys and is potentially nephrotoxic. |
|
| FDA_UNII_Code |
875Y4127EA |
|
| in_subset | ||
| label |
Hetastarch |
|
| Legacy Concept Name |
Hetastarch |
|
| NCI_Drug_Dictionary_ID |
735726 |
|
| PDQ_Closed_Trial_Search_ID |
735726 |
|
| PDQ_Open_Trial_Search_ID |
735726 |
|
| Preferred_Name |
Hetastarch |
|
| prefixIRI |
NCIT:C559 |
|
| prefLabel |
Hetastarch |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0020352 |
|
| subClassOf |